# A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes

Study · id `cardio:ct-nct02861261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02861261](<https://clinicaltrials.gov/study/NCT02861261>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02861261

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02861261. Randomized; double masking; primary purpose treatment. Start 2016-08-18 (actual); primary completion 2017-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02861261, source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)
- Started: 2016-08-18 (actual) (ClinicalTrials.gov record NCT02861261, source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)
- Primary completion: 2017-12 (actual) (ClinicalTrials.gov record NCT02861261, source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)
- Completion: 2019-05 (anticipated) (ClinicalTrials.gov record NCT02861261, source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02861261, source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02861261-2019-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Drug): 1. Berberine hydrochloride tablets ; 2. ProMetS probiotics powder
- Intervention (Drug): 1. Berberine placebo tablets ; 2. ProMetS probiotics powder
- Intervention (Drug): 1. Berberine hydrochloride tablets; 2. Probiotics placebo powder
- Intervention (Drug): 1. Berberine placebo tablets; 2. Probiotics placebo powder
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) (`cardio:pubmed-33024120`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 96c7c3cef309b7248f625d5d876147868a664bfc1ee5847bb83e48c8ad1ab8c0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
